COVID-19 and malaria co-infection: a systematic review of clinical outcomes in endemic areas
Open Access
Abstract
Background: COVID-19 and malaria cause significant morbidity and mortality globally. Co-infection of these diseases can worsen their impact on public health. This review aims to synthesize literature on the clinical outcomes of COVID-19 and malaria co-infection to develop effective prevention and treatment strategies. Methods: A comprehensive literature search was conducted using MeSH terms and keywords from the start of the COVID-19 pandemic to January 2023. The review included original articles on COVID-19 and malaria co-infection, evaluating their methodological quality and certainty of evidence. It was registered in PROSPERO (CRD42023393562). Results: Out of 1,596 screened articles, 19 met the inclusion criteria. These studies involved 2,810 patients, 618 of whom had COVID-19 and malaria co-infection. Plasmodium falciparum and vivax were identified as causative organisms in six studies. Hospital admission ranged from three to 18 days. Nine studies associated co-infection with severe disease, ICU admission, assisted ventilation, and related complications. One study reported 6% ICU admission, and mortality rates of 3%, 9.4%, and 40.4% were observed in four studies. Estimated crude mortality rates were 10.71 and 5.87 per 1,000 person-days for patients with and without concurrent malaria, respectively. Common co-morbidities included Diabetes mellitus, hypertension, cardiovascular diseases, and respiratory disorders. Conclusion: Most patients with COVID-19 and malaria co-infection experienced short-term hospitalization and mild to moderate disease severity. However, at presentation, co-morbidities and severe malaria were significantly associated with higher mortality or worse clinical outcomes. These findings emphasize the importance of early detection, prompt treatment, and close monitoring of patients with COVID-19 and malaria co-infection.Keywords
Funding Information
- Deputyship for Research & Innovation, Ministry of Education in Saudi Arabia (ISP-2024)
This publication has 57 references indexed in Scilit:
- Profiles of host immune impairment in Plasmodium and SARS-CoV-2 infectionsHeliyon, 2022
- Prevalence of Malaria and Covid-19 in Febrile Patients in Lomé, Togo in 2020Acta Parasitologica, 2022
- Clinical characteristics, complications, and predictors of outcome of hospitalized adult Sudanese patients with COVID‐19 and malaria coinfection in Sudan: A multicenter retrospective cross‐sectional studyJournal of Medical Virology, 2022
- Impact of COVID-19 and malaria coinfection on clinical outcomes: a retrospective cohort studyClinical Microbiology and Infection, 2022
- Assessment of Clinical Outcomes Among Children and Adolescents Hospitalized With COVID-19 in 6 Sub-Saharan African CountriesJAMA Pediatrics, 2022
- COVID-19, cytokines, inflammation, and spices: How are they related?Life Sciences, 2021
- COVID-19 and malaria, a tale of two diseasesEBioMedicine, 2021
- Insights into Plasmodium and SARS-CoV-2 co-infection driven neurological manifestationsBiosafety and Health, 2021
- COVID-19: Possible Cause of Induction of Relapse of Plasmodium vivax InfectionIndian Journal of Pediatrics, 2020
- Understanding predictors of prolonged hospitalizations among general medicine patients: A guide and preliminary analysisJournal of Hospital Medicine, 2015